AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 45(2), 1991, pp. 175-181
Copyright © 1991 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huijun, Z.
Right arrow Articles by Piessens, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huijun, Z.
Right arrow Articles by Piessens, W. F.

Efficacy of Ivermectin for Control of Microfilaremia Recurring after Treatment with Diethylcarbamazine

II. Immunologic Changes Following Treatment

Zheng Huijun, Tao Zhenghou, Cheng Wenfang, Wang Shihai, Cheng Shizhi, Ye Yangming, Luo Laifeng, Chen Xiaorui, Gan Genbao AND Willy F. Piessens
Guizhou Provincial Institute of Parasitic Diseases and Guizhou Provincial Institute of Pharmacology and Drug Control, Guiyang, Guizhou, People's Republic of China; Tongren and Zunyi Prefecture Sanitary and Antiepidemic Stations, Guizhou, People's Republic of China; Harvard School of Public Health, Boston, Massachusetts

We compared the effect of a single dose of ivermectin with that of a standard course of diethylcarbamazine (DEC) on several parameters of the host's antifilarial immune response in 60 patients with bancroftian filariasis enrolled in a double-blind drug trial. All participants had measurable serum levels of antifilarial antibodies and parasite antigens at the onset of the study. Drug-induced clearance of microfilaremia was associated with a temporary increase in HC 11 antigenemia and a decrease in serum levels of antibodies to soluble filarial antigens. Antigenemia progressively declined in patients who remained amicrofilaremic. Treatment triggered a sustained increase in serum levels of interleukin-1, tumor necrosis factor, and interleukin-6 in all patients studied. Although ivermectin and DEC are believed to exert their antiparasite activity via different mechanisms, the same pattern of serologic changes was observed in patients treated with either drug.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Tropical Medicine and Hygiene.